Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study

Vixotrigine is a state‐ and use‐dependent Nav1.7 channel blocker being investigated for the treatment of neuropathic pain conditions. This randomized, double‐blind, placebo‐controlled crossover trial was designed to evaluate changes in blood pressure with the administration of vixotrigine using ambu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Regan, Ballow, Charles H., Naik, Himanshu, Steiner, Deb, Palmer, Joanne, White, William B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586067/
https://www.ncbi.nlm.nih.gov/pubmed/30144099
http://dx.doi.org/10.1002/jcph.1298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586067/
https://www.ncbi.nlm.nih.gov/pubmed/30144099
http://dx.doi.org/10.1002/jcph.1298

Ejemplares similares